Found: 19
Select item for more details and to access through your institution.
Detection of ALK fusion transcripts in FFPE lung cancer samples by NanoString technology.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Brazilian Expert Consensus for NTRK Gene Fusion Testing in Solid Tumors.
- Published in:
- Clinical Pathology, 2023, p. 1, doi. 10.1177/2632010X231197080
- By:
- Publication type:
- Article
Brazilian Expert Consensus for NTRK Gene Fusion Testing in Solid Tumors.
- Published in:
- Clinical Pathology, 2023, v. 16, p. 1, doi. 10.1177/2632010X231197080
- By:
- Publication type:
- Article
Real-World Prevalence of PD-L1 Expression Among Tumor Samples From Patients With Non-Small-Cell Lung Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
HMGB1 Expression Levels Correlate with Response to Immunotherapy in Non-Small Cell Lung Cancer.
- Published in:
- Lung Cancer: Targets & Therapy, 2024, v. 15, p. 55, doi. 10.2147/LCTT.S455034
- By:
- Publication type:
- Article
DNA Methylation Markers from Negative Surgical Margins Can Predict Recurrence of Oral Squamous Cell Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 12, p. 2915, doi. 10.3390/cancers13122915
- By:
- Publication type:
- Article
EGF+61 A>G polymorphism is not associated with lung cancer risk in the Brazilian population.
- Published in:
- Molecular Biology Reports, 2019, v. 46, n. 2, p. 2417, doi. 10.1007/s11033-019-04702-0
- By:
- Publication type:
- Article
ERBB2 exon 20 insertions are rare in Brazilian non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 23, p. 3402, doi. 10.1111/1759-7714.14605
- By:
- Publication type:
- Article
EGF+61 A>G polymorphism does not predict response to first‐generation EGFR tyrosine kinase inhibitors in lung cancer patients.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 10, p. 2987, doi. 10.1111/1759-7714.13628
- By:
- Publication type:
- Article
Impact of AferBio® on quality of life and chemotherapy toxicity in advanced lung cancer patients (AFERBIO study): protocol study for a phase II randomized controlled trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma.
- Published in:
- BMC Cancer, 2018, v. 18, n. 1, p. 1, doi. 10.1186/s12885-018-4893-5
- By:
- Publication type:
- Article
Evaluation of acetylation and methylation in oral rinse of patients with head and neck cancer history exposed to valproic acid.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-95845-3
- By:
- Publication type:
- Article
Impact of genetic variants in clinical outcome of a cohort of patients with oropharyngeal squamous cell carcinoma.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-66741-z
- By:
- Publication type:
- Article
Disruptive and Truncating TP53 Mutations Are Associated with African-Ancestry and Worse Prognosis in Brazilian Patients with Lung Adenocarcinoma.
- Published in:
- Pathobiology, 2023, v. 90, n. 5, p. 344, doi. 10.1159/000530587
- By:
- Publication type:
- Article
Microsatellite Instability Is Rare in the Admixed Brazilian Population of Non-Small Cell Lung Cancer: A Cohort of 526 Cases.
- Published in:
- Pathobiology, 2022, v. 89, n. 2, p. 101, doi. 10.1159/000520023
- By:
- Publication type:
- Article
Molecular profile of driver genes in lung adenocarcinomas of Brazilian patients who have never smoked: implications for targeted therapies.
- Published in:
- Oncologist, 2024, v. 29, n. 10, p. e1419, doi. 10.1093/oncolo/oyae129
- By:
- Publication type:
- Article
Dealing with lung cancer in the COVID-19 scenario (A review).
- Published in:
- Molecular & Clinical Oncology, 2021, v. 14, n. 2, p. N.PAG
- By:
- Publication type:
- Article
Mutational profile of Brazilian lung adenocarcinoma unveils association of EGFR mutations with high Asian ancestry and independent prognostic role of KRAS mutations.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-39965-x
- By:
- Publication type:
- Article
Using Co-segregation and Loss of Heterozygosity Analysis to Define the Pathogenicity of Unclassified Variants in Hereditary Breast Cancer Patients.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.571330
- By:
- Publication type:
- Article